How Can Counsel for Recreational Marijuana Companies Defend Against Failure to Warn Lawsuits?
In The News | 1 min read
May 12, 2021
Hinshaw attorney Michael Adams recently published a byline in DRI's For the Defense magazine on the rising risk of failure to warn lawsuits confronting the recreational marijuana industry. With the marijuana industry one of the fastest growing industries in the United States, it is reasonable to anticipate that more tort-based lawsuits will be filed against it. In the article, Adams compares defenses used in failure to warn lawsuits filed against the alcohol and tobacco industries, and discusses what lessons those claims may have for marijuana companies.
Adams notes that under federal law marijuana remains an illegal Schedule I drug under the Controlled Substances Act. As such, defendants in the retail marijuana industry cannot invoke defenses based on federal labeling requirements. Instead, failure to warn claims against the recreational marijuana industry implicate state regulatory schemes, as well as the common law. Adams reviews potential defenses available based on compliance with state statutes and regulations, as well as the process of assessing whether product warnings and instructions are adequate.
Read the full article (PDF)
"Failure to Warn Claims Against the Recreational Marijuana Industry" was published by DRI's For the Defense Magazine, April 2021.
Related People
Related Capabilities
Featured Insights

Event
Apr 23, 2026
Driving Ahead: Insights from Industry Leaders Auto Finance Seminar

Healthcare Alert
Mar 26, 2026
Are You Beyond the Red Line? Mastering Your FQHC’s Scope of Project to Avoid Noncompliance

Webinar
Mar 24, 2026
David Alfini on How Regulatory Citations Become Senior Living Risk

Consumer Crossroads: Where Financial Services and Litigation Intersect
Mar 18, 2026
How Should Entities Prepare for California’s New DFAL Licensing Requirement?

Webinar
Mar 17, 2026
Legal Insights on Medical Aid in Dying from Katie Anderson and Adam Guetzow

Consumer Crossroads: Where Financial Services and Litigation Intersect
Mar 13, 2026
DOJ Settlement with Car Retailer Highlights SCRA Repossession Risks

Privacy, Cyber & AI Decoded Alert
Mar 11, 2026
Compliance Considerations for GDPR Consent in Biotech Clinical Research





![[VIDEO] Lucy Wang Featured in Business Interview TV Series](/a/web/28aUdvEJH2Txwy8MGsu35J/bo3TFX/featured-in-the-business-insurance-business-interview-series-insights.jpg)
